An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

Name: An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha
Published: 1999
License: Public Domain

Novartis Pharmaceuticals · 1999

ClinicalTrials.gov · Datasets · License: Public Domain · 1999

Open Source ↗

chronic leukemia

leukemia, myelogenous, chronic, bcr-abl positive, chronic myelogenous leukemia, cml, philadelphia chromosome, accelerated phase, acute myelogenous leukemia, aml, acute lymphoblastic leukemia, all, imatinib mesylate, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

Related documents